非酒精性脂肪性肝病的靶向治疗研究进展
非酒精性脂肪性肝病（NAFLD）是最常见的进行性疾病，临床上目前尚无疗效确切的治疗药物。介绍了脂肪酸-胆酸偶合物（FABACs）和熊去氧胆酸-溶血磷脂酰乙醇胺偶合物（UDCA-LPE）两种新型的具有NAFLD防治作用的肝靶向药物的研究进展。FABACs通过调节脂代谢，特异性的降低高脂饲料所致NAFLD的肝脏脂肪升高，预防NAFLD的形成；而且对已形成的NAFLD也有治疗作用；Ⅱ期临床研究结果显示其起效快、安全性好。UDCA-LPE在降低NAFLD的肝脏脂肪的同时，能够抑制线粒体损伤和凋亡，促进肝细胞再生，对NAFLD发展过程中的相关炎症具有显著的抑制作用。因此，FABACs和UDCA-LPE对...
Saved in:
| Published in | 临床肝胆病杂志 Vol. 30; no. 5; pp. 469 - 472 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
解放军总医院和解放军医学院,北京,100853%解放军第302医院,北京,100039
2014
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1001-5256 |
| DOI | 10.3969/j.issn.1001-5256.2014.05.024 |
Cover
| Abstract | 非酒精性脂肪性肝病（NAFLD）是最常见的进行性疾病，临床上目前尚无疗效确切的治疗药物。介绍了脂肪酸-胆酸偶合物（FABACs）和熊去氧胆酸-溶血磷脂酰乙醇胺偶合物（UDCA-LPE）两种新型的具有NAFLD防治作用的肝靶向药物的研究进展。FABACs通过调节脂代谢，特异性的降低高脂饲料所致NAFLD的肝脏脂肪升高，预防NAFLD的形成；而且对已形成的NAFLD也有治疗作用；Ⅱ期临床研究结果显示其起效快、安全性好。UDCA-LPE在降低NAFLD的肝脏脂肪的同时，能够抑制线粒体损伤和凋亡，促进肝细胞再生，对NAFLD发展过程中的相关炎症具有显著的抑制作用。因此，FABACs和UDCA-LPE对防治NAFLD具有良好的应用前景。 |
|---|---|
| AbstractList | R575.5; 非酒精性脂肪性肝病（NAFLD）是最常见的进行性疾病，临床上目前尚无疗效确切的治疗药物。介绍了脂肪酸-胆酸偶合物（FABACs）和熊去氧胆酸-溶血磷脂酰乙醇胺偶合物（UDCA-LPE）两种新型的具有NAFLD防治作用的肝靶向药物的研究进展。FABACs通过调节脂代谢，特异性的降低高脂饲料所致NAFLD的肝脏脂肪升高，预防NAFLD的形成；而且对已形成的NAFLD也有治疗作用；Ⅱ期临床研究结果显示其起效快、安全性好。UDCA-LPE在降低NAFLD的肝脏脂肪的同时，能够抑制线粒体损伤和凋亡，促进肝细胞再生，对NAFLD发展过程中的相关炎症具有显著的抑制作用。因此，FABACs和UDCA-LPE对防治NAFLD具有良好的应用前景。 非酒精性脂肪性肝病（NAFLD）是最常见的进行性疾病，临床上目前尚无疗效确切的治疗药物。介绍了脂肪酸-胆酸偶合物（FABACs）和熊去氧胆酸-溶血磷脂酰乙醇胺偶合物（UDCA-LPE）两种新型的具有NAFLD防治作用的肝靶向药物的研究进展。FABACs通过调节脂代谢，特异性的降低高脂饲料所致NAFLD的肝脏脂肪升高，预防NAFLD的形成；而且对已形成的NAFLD也有治疗作用；Ⅱ期临床研究结果显示其起效快、安全性好。UDCA-LPE在降低NAFLD的肝脏脂肪的同时，能够抑制线粒体损伤和凋亡，促进肝细胞再生，对NAFLD发展过程中的相关炎症具有显著的抑制作用。因此，FABACs和UDCA-LPE对防治NAFLD具有良好的应用前景。 |
| Abstract_FL | Nonalcoholic fatty liver disease (NAFLD)is the most common progressive liver disease worldwide.Currently,there is no satisfy-ing treatment for NAFLD.Research progress in fatty acid bile acid conjugates (FABACs)and ursodeoxycholyl lysophosphatidylethanolamide (UDCA-LPE),which are two novel liver targeted drugs with anti-NAFLD effects,is reviewed.FABACs,which reduce liver fat in pa-tients with NAFLD induced by high-fat diet by regulating lipid metabolism,have been proved effective in preventing and treating NAFLD. The safety and efficacy of FABACs in NAFLD patients have been confirmed in a phase II,randomized,double-blind,placebo-controlled trial.UDCA-LPE can not only reduce liver fat in NAFLD patients,but also inhibit mitochondrial damage and apoptosis and promote hepa-tocyte regeneration,with a marked anti-inflammatory effect during the development of NAFLD.Therefore,FABACs and UDCA-LPE hold promise for preventing and treating NAFLD. |
| Author | 靳雪源（综述） 王慧芬（审校） |
| AuthorAffiliation | 解放军总医院和解放军医学院,北京100853 解放军第302医院,北京100039 |
| AuthorAffiliation_xml | – name: 解放军总医院和解放军医学院,北京,100853%解放军第302医院,北京,100039 |
| Author_FL | WANG Huifen JIN Xueyuan |
| Author_FL_xml | – sequence: 1 fullname: JIN Xueyuan – sequence: 2 fullname: WANG Huifen |
| Author_xml | – sequence: 1 fullname: 靳雪源（综述） 王慧芬（审校） |
| BookMark | eNo9j71KA0EcxLeIYIx5CMHC5s7_7t7u3pYS_IKATfqwex_xQtzTO0RMJSHpjagBJWIn2pkijaBPk9zdW5gQsZph-DHDbKCSiU2A0DYGm0oud9t2lKbGxgDYYoRxmwB2bGA2EKeEyv_5OqqmaaSBYcqlw3gZ8WL8Ugzussn3_OYt7_fy3sfS9MbZaJA99YvxdHY7nE--ssdR9nqfvU_zn-fZ58MmWgtVJw2qf1pBjYP9Ru3Iqp8cHtf26pbHJFjYFY4PVEgZaCE9yXEYEC1CH2vihYAVYC5AaNdVlGhFBaWCUy19TKQfOkAraGdVe6VMqEyr2Y4vE7MYbHa8lq-73eVPYECX6NYK9U5j07qIFvB5Ep2p5LrpSME4uC79BaHCaWE |
| ClassificationCodes | R575.5 |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3969/j.issn.1001-5256.2014.05.024 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Research progress in liver targeted therapy for nonalcoholic fatty liver disease |
| DocumentTitle_FL | Research progress in liver targeted therapy for nonalcoholic fatty liver disease |
| EndPage | 472 |
| ExternalDocumentID | lcgdbzz201405030 49756088 |
| GrantInformation_xml | – fundername: 国家自然科学基金; 国家863计划项目 funderid: (30972626); (2006AA02A4C6) |
| GroupedDBID | -05 2B. 2C~ 2RA 5XA 5XF 92F 92I 92L ABDBF ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 EAD EAP EOJEC ESX GROUPED_DOAJ IPNFZ OBODZ OK1 RIG RNS TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI ACUHS PSX |
| ID | FETCH-LOGICAL-c590-1874d03799eb79c961fe2b7fd1b2cf01a016707b88a32ba3733763b9d129df403 |
| ISSN | 1001-5256 |
| IngestDate | Thu May 29 03:59:49 EDT 2025 Wed Feb 14 10:37:16 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | 脂肪肝 ursodeoxycholyl lysophosphatidylethanolamide 熊去氧胆酸-溶血磷脂酰乙醇胺偶合物 fatty acid bile acid conjugates review fatty liver 综述 脂肪酸-胆酸偶合物 |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c590-1874d03799eb79c961fe2b7fd1b2cf01a016707b88a32ba3733763b9d129df403 |
| Notes | fatty liver;fatty acid bile acid conjugates;ursodeoxycholyl lysophosphatidylethanolamide;review Nonalcoholic fatty liver disease （NAFLD）is the most common progressive liver disease worldwide.Currently,there is no satisfying treatment for NAFLD.Research progress in fatty acid bile acid conjugates （FABACs）and ursodeoxycholyl lysophosphatidylethanolamide （UDCA-LPE）,which are two novel liver targeted drugs with anti-NAFLD effects,is reviewed.FABACs,which reduce liver fat in patients with NAFLD induced by high-fat diet by regulating lipid metabolism,have been proved effective in preventing and treating NAFLD. The safety and efficacy of FABACs in NAFLD patients have been confirmed in a phase II,randomized,double-blind,placebo-controlled trial.UDCA-LPE can not only reduce liver fat in NAFLD patients,but also inhibit mitochondrial damage and apoptosis and promote hepatocyte regeneration,with a marked anti-inflammatory effect during the development of NAFLD.Therefore,FABACs and UDCA-LPE hold promise for preventing and |
| PageCount | 4 |
| ParticipantIDs | wanfang_journals_lcgdbzz201405030 chongqing_primary_49756088 |
| PublicationCentury | 2000 |
| PublicationDate | 2014 |
| PublicationDateYYYYMMDD | 2014-01-01 |
| PublicationDate_xml | – year: 2014 text: 2014 |
| PublicationDecade | 2010 |
| PublicationTitle | 临床肝胆病杂志 |
| PublicationTitleAlternate | Chinese Journal of Clinical Hepatology |
| PublicationTitle_FL | Journal of Clinical Hepatology |
| PublicationYear | 2014 |
| Publisher | 解放军总医院和解放军医学院,北京,100853%解放军第302医院,北京,100039 |
| Publisher_xml | – name: 解放军总医院和解放军医学院,北京,100853%解放军第302医院,北京,100039 |
| SSID | ssib051369456 ssj0041983 ssib001103858 ssib053243598 ssib002264326 ssib038074677 |
| Score | 1.9670697 |
| Snippet | ... R575.5;... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 469 |
| SubjectTerms | 熊去氧胆酸-溶血磷脂酰乙醇胺偶合物 综述 脂肪肝 脂肪酸-胆酸偶合物 |
| Title | 非酒精性脂肪性肝病的靶向治疗研究进展 |
| URI | http://lib.cqvip.com/qk/90100X/201405/49756088.html https://d.wanfangdata.com.cn/periodical/lcgdbzz201405030 |
| Volume | 30 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LThRBsMMjIV6Mzwg-ggl9XJzp6e7pPnYPQ4gJnjDhttmZ2YGDWXzAZU-GwF2NSqLBeDN6kwMXE_0AvwMW_sKqnt7dgSBBL5NKd1VtPWa2qztV1YTM5EHcErFuN8pWyBpcFLqhVcnBIToSEbwxLMeN4uIjufCYP1wWyyOjv2tZSxvr2WzePbOu5H-8CmPgV6yS_QfPDpjCAMDgX3iCh-F5IR_TVFM9R3WKgBJUM5rG1DJqYURiEoOJaaqogoCROYBRY05OMeQAVDpGDggYxK84W0lTYBtQHSIVcrYORyI-AAamuAO0Q1bUzlNtkcqGtLrYsh_70pRTCwjczcKvmJoAAERUyZokEsdRbOF4DtbLvmiRA6xXCPiBmEw5A1hqEy-LDWpnHTipUqqsM4Hom8BQkzhSGEmpcaqCYgB4Un8qEg7PQ5EOqE3k5OTO4ALl19ab1zojqMQBIKimxukCPlLJueQDKhBnjho5JGeJn0Xjc9QZBU-wcxJeKyLOZRsjskmigJ0h2N85B1UXKL9wYWqcYFWTdv_NitrCxKsLcXyMw6vrkk4vn5GW2i2fyHJ2wBITILnrb1uVu59qUP4kXymybheRsLlQMErGWSwlGyPjxs7Z-WF0HgYnWidhDXdt94BXH_Bad0URRlLzYasnAbE_9pvsB1o81Kqqn_FyTpAZr8SD81TALiqra52VZxAbulK9TtnqrNSiyqUr5LLfDk6b6tu-Ska6q9fIxKJPeLlO5PHup-PtN729n4cvvxxtbR5tfkNgc7e3s937sHW8u3_w6vXh3o_e-53e57e9r_tHvz4efH93gyzNp0vJQsNfddLIhcbkipgXQRRr3c5inWsZlm2WxWURZiwvg7CFxUJBnCnViljWiuII44JMFxCtFyUPoptkrLPWad8i02UYgml1wSXHboUl_PHmhSx40ZaqzAoxSaYG2jefVh1tmlzHsPNRapLc9-Zo-r-5F83T7p26AM5tcgnh6qjyDhlbf77RvgvB-3p2z78UfwCdh6mT |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%9D%9E%E9%85%92%E7%B2%BE%E6%80%A7%E8%84%82%E8%82%AA%E6%80%A7%E8%82%9D%E7%97%85%E7%9A%84%E9%9D%B6%E5%90%91%E6%B2%BB%E7%96%97%E7%A0%94%E7%A9%B6%E8%BF%9B%E5%B1%95&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E9%9D%B3%E9%9B%AA%E6%BA%90%28%E7%BB%BC%E8%BF%B0%29&rft.au=%E7%8E%8B%E6%85%A7%E8%8A%AC%28%E5%AE%A1%E6%A0%A1%29&rft.date=2014&rft.pub=%E8%A7%A3%E6%94%BE%E5%86%9B%E6%80%BB%E5%8C%BB%E9%99%A2%E5%92%8C%E8%A7%A3%E6%94%BE%E5%86%9B%E5%8C%BB%E5%AD%A6%E9%99%A2%2C%E5%8C%97%E4%BA%AC%2C100853%25%E8%A7%A3%E6%94%BE%E5%86%9B%E7%AC%AC302%E5%8C%BB%E9%99%A2%2C%E5%8C%97%E4%BA%AC%2C100039&rft.issn=1001-5256&rft.issue=5&rft.spage=469&rft.epage=472&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2014.05.024&rft.externalDocID=lcgdbzz201405030 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90100X%2F90100X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg |